Telomir Pharmaceuticals TELO Cash Flow Statement (2023-2026)

NASDAQ TELO

$1.12 -0.05 (-4.27%)

At close: Aug 20, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Operating Activities
Share-based Compensation (Quarter)							4.30M	-0.81M	1.38M	3.82M	0.13M	10.96M	0.59M
Cash from Operations (Quarter)	-0.74M	-0.03M	-2.00M	-1.09M	-1.94M	-1.52M	-1.00M	-0.61M	-0.90M	-0.70M	-0.90M	-1.20M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)			0.01M	1.60M	4.34M
Change in Working Capital
Change in Accured Expenses (Quarter)	-0.25M	1.39M	-1.05M	0.02M	0.07M	-0.08M	0.11M	0.08M	-0.03M	-0.30M	0.07M	0.21M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)	0.26M	0.32M	0.13M	0.95M	0.52M		-0.09M	-0.87M
Short-Term Debt issuances (Quarter)			0.85M	0.11M	0.10M
Change in Capital Stock
Shares Issued (Quarter)				2.81M			2.37M	2.35M	2.34M	4.24M	4.19M	4.19M	4.32M
Net Equity Issued and Repurchased (Quarter)	1.00M	-0.09M		0.09M	5.83M			1.00M			4.50M		0.00M
Misc.
Cash from Financing Activities (Quarter)	0.74M	0.05M	1.99M	1.09M	5.21M	0.13M	-0.05M	1.04M			7.50M	1.16M
Change in Cash (Quarter)	388.00	0.01M	-0.01M	-0.00M	3.27M	-1.39M	-1.05M	0.43M	-0.86M	0.35M	6.57M	-0.04M
Free Cash Flow (Quarter)	-0.74M	-0.03M	-2.00M	-1.09M	-1.94M	-1.52M	-1.00M	-0.61M	-0.90M	-0.70M	-0.90M	-1.20M
Net Cash Flow (Quarter)	388.00	0.01M	-0.01M	-0.00M	3.27M	-1.39M	-1.05M	0.43M	-0.90M	-0.70M	6.60M	-0.04M

Telomir Pharmaceuticals (TELO)

NASDAQ: TELO

$1.12 ▼ -0.05 (-4.27%)

Aug 20, 2026 · 4:00 PM EDT